Aurora Cannabis (ACB) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

ACB Stock Forecast


Aurora Cannabis stock forecast is as follows: an average price target of $5.92 (represents a -1.00% downside from ACB’s last price of $5.98) and a rating consensus of 'Hold', based on 7 wall street analysts offering a 1-year stock forecast.

ACB Price Target


The average price target for Aurora Cannabis (ACB) is $5.92 based on 1-year price targets from 7 Wall Street analysts in the past 3 months, with a price target range of $8.75 to $1.00. This represents a potential -1.00% downside from ACB's last price of $5.98.

ACB Analyst Ratings


Hold

According to 7 Wall Street analysts, Aurora Cannabis's rating consensus is 'Hold'. The analyst rating breakdown for ACB stock is 0 'Strong Buy' (0.00%), 2 'Buy' (28.57%), 5 'Hold' (71.43%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Aurora Cannabis Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 11, 2023EBITDA Q3Piper Sandler$1.00$0.8814.06%-83.28%
May 28, 2021Heather BalskyBank of America Securities$8.75$9.66-9.39%46.37%
May 14, 2021Tamy ChenBMO Capital$8.00$6.8616.62%33.78%
Row per page
Go to

The latest Aurora Cannabis stock forecast, released on Jan 11, 2023 by EBITDA Q3 from Piper Sandler, set a price target of $1.00, which represents a 14.06% increase from the stock price at the time of the forecast ($0.88), and a -83.28% decrease from ACB last price ($5.98).

Aurora Cannabis Price Target by Period


1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$5.98$5.98$5.98
Upside/Downside-100.00%-100.00%-100.00%

In the current month, the average price target of Aurora Cannabis stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Aurora Cannabis's last price of $5.98. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Feb 16, 2024Canaccord GenuityHoldPositiveUpgrade
Sep 21, 2022Canaccord Genuity-HoldDowngrade
Sep 21, 2022Maxim Group-HoldDowngrade
Sep 21, 2022Needham-HoldInitialise
Sep 21, 2022Exane BNP Paribas-OutperformInitialise
Sep 21, 2022Wolfe Research-Peer PerformInitialise
Sep 21, 2022Barclays-Equal-WeightDowngrade
Sep 21, 2022Piper SandlerNeutralNeutralHold
Jun 24, 2022Cantor Fitzgerald-NeutralUpgrade
Row per page
Go to

Aurora Cannabis's last stock rating was published by Canaccord Genuity on Feb 16, 2024. The company Upgrade its ACB rating from "Hold" to "Positive".

Aurora Cannabis Financial Forecast


Aurora Cannabis Revenue Forecast

Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19
Revenue-----------------$61.68M$49.26M$50.22M$50.43M$60.59M$60.11M$54.61M$55.16M$67.67M$67.81M$72.11M$75.52M$56.03M
Avg Forecast$57.30M$53.51M$54.73M$65.47M$54.15M$50.50M$50.79M$62.25M$55.79M$51.95M$51.56M$56.67M$51.34M$47.82M$46.44M$56.86M$50.24M$47.95M$40.45M$40.81M$45.53M$54.68M$54.50M$47.59M$53.72M$47.58M$46.64M$67.95M$82.61M$48.70M
High Forecast$57.30M$53.51M$54.73M$65.47M$54.15M$50.50M$50.79M$62.25M$55.79M$51.95M$52.37M$56.67M$51.34M$48.51M$46.44M$56.86M$50.24M$47.95M$40.45M$40.81M$45.53M$54.68M$54.50M$47.59M$53.72M$47.58M$46.64M$67.95M$82.61M$48.70M
Low Forecast$57.30M$53.51M$54.73M$65.47M$54.15M$50.50M$50.79M$62.25M$55.79M$51.95M$50.74M$56.67M$51.34M$47.29M$46.44M$56.86M$50.24M$47.95M$40.45M$40.81M$45.53M$54.68M$54.50M$47.59M$53.72M$47.58M$46.64M$67.95M$82.61M$48.70M
# Analysts1111111111211311111111177111010116
Surprise %-----------------1.29%1.22%1.23%1.11%1.11%1.10%1.15%1.03%1.42%1.45%1.06%0.91%1.15%

Aurora Cannabis's average Quarter revenue forecast for Mar 23 based on 1 analysts is $50.24M, with a low forecast of $50.24M, and a high forecast of $50.24M. ACB's average Quarter revenue forecast represents a -18.55% decrease compared to the company's last Quarter revenue of $61.68M (Dec 22).

Aurora Cannabis EBITDA Forecast

Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19
# Analysts1111111111211311111111177111010116
EBITDA-----------------$-53.87M$-38.34M$-61.90M$-52.21M$-33.60M$27.84M$-87.03M$-132.22M$-249.73M$-66.45M$-1.89B$-112.98M$-1.25B
Avg Forecast$-34.77M$-32.46M$-33.20M$-39.72M$-32.85M$-30.64M$-30.81M$-37.76M$-33.85M$-31.52M$-31.28M$-34.38M$-31.15M$-29.02M$-28.17M$-34.50M$-30.48M$-29.09M$-24.54M$-24.76M$-19.16B$-33.18M$-33.07M$-28.87M$-233.98M$-28.87M$-28.30M$-41.22M$-94.97M$-29.55M
High Forecast$-34.77M$-32.46M$-33.20M$-39.72M$-32.85M$-30.64M$-30.81M$-37.76M$-33.85M$-31.52M$-30.78M$-34.38M$-31.15M$-28.69M$-28.17M$-34.50M$-30.48M$-29.09M$-24.54M$-24.76M$-15.33B$-33.18M$-33.07M$-28.87M$-187.19M$-28.87M$-28.30M$-41.22M$-75.97M$-29.55M
Low Forecast$-34.77M$-32.46M$-33.20M$-39.72M$-32.85M$-30.64M$-30.81M$-37.76M$-33.85M$-31.52M$-31.77M$-34.38M$-31.15M$-29.43M$-28.17M$-34.50M$-30.48M$-29.09M$-24.54M$-24.76M$-23.00B$-33.18M$-33.07M$-28.87M$-280.78M$-28.87M$-28.30M$-41.22M$-113.96M$-29.55M
Surprise %-----------------1.85%1.56%2.50%0.00%1.01%-0.84%3.01%0.57%8.65%2.35%45.76%1.19%42.48%

1 analysts predict ACB's average Quarter EBITDA for Dec 21 to be $-33.18M, with a high of $-33.18M and a low of $-33.18M. This is -219.18% lower than Aurora Cannabis's previous annual EBITDA (Sep 21) of $27.84M.

Aurora Cannabis Net Income Forecast

Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19
# Analysts1111111111211311111111177111010116
Net Income-----------------$-67.18M$-51.89M$-618.78M$-1.01B$-75.14M$-11.88M$-128.13M$-164.65M$-292.79M$-108.06M$-1.87B$-137.40M$-1.29B
Avg Forecast$5.51M$5.51M$5.05M$2.29M$1.84M$1.84M$1.38M$-1.84M$-1.71M$-3.99M$-5.10M$-8.21M$-8.55M$-6.37M$-30.73M$-24.65M$-18.97M$-122.21M$-40.52M$-60.45M$-20.11B$-117.91M$-146.05M$-183.46M$-291.38M$-352.53M$-480.12M$-308.54M$-115.49M$-275.80M
High Forecast$5.51M$5.51M$5.05M$2.29M$1.84M$1.84M$1.38M$-1.84M$-1.71M$-3.99M$1.02M$-8.21M$-8.55M$-6.37M$-10.24M$-24.65M$-18.97M$-122.21M$-40.52M$-60.45M$-16.09B$-117.91M$-146.05M$-183.46M$-233.10M$-352.53M$-480.12M$-308.54M$-92.39M$-275.80M
Low Forecast$5.51M$5.51M$5.05M$2.29M$1.84M$1.84M$1.38M$-1.84M$-1.71M$-3.99M$-11.23M$-8.21M$-8.55M$-6.37M$-40.97M$-24.65M$-18.97M$-122.21M$-40.52M$-60.45M$-24.13B$-117.91M$-146.05M$-183.46M$-349.65M$-352.53M$-480.12M$-308.54M$-138.59M$-275.80M
Surprise %-----------------0.55%1.28%10.24%0.05%0.64%0.08%0.70%0.57%0.83%0.23%6.07%1.19%4.66%

Aurora Cannabis's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. ACB's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Aurora Cannabis SG&A Forecast

Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19
# Analysts1111111111211311111111177111010116
SG&A-----------------$44.57M$45.04M$50.36M$43.17M$46.86M$48.61M$48.82M$46.92M$47.96M$51.19M$41.36M$89.35M$119.84M
Avg Forecast$49.20M$45.94M$46.99M$56.21M$46.50M$43.36M$43.60M$53.45M$47.90M$44.60M$44.27M$48.66M$44.08M$41.06M$39.87M$48.82M$43.13M$41.17M$34.73M$35.04M$39.09M$46.95M$46.80M$40.86M$46.12M$40.86M$40.05M$58.34M$75.11M$41.81M
High Forecast$49.20M$45.94M$46.99M$56.21M$46.50M$43.36M$43.60M$53.45M$47.90M$44.60M$44.97M$48.66M$44.08M$41.65M$39.87M$48.82M$43.13M$41.17M$34.73M$35.04M$39.09M$46.95M$46.80M$40.86M$46.12M$40.86M$40.05M$58.34M$90.13M$41.81M
Low Forecast$49.20M$45.94M$46.99M$56.21M$46.50M$43.36M$43.60M$53.45M$47.90M$44.60M$43.57M$48.66M$44.08M$40.61M$39.87M$48.82M$43.13M$41.17M$34.73M$35.04M$39.09M$46.95M$46.80M$40.86M$46.12M$40.86M$40.05M$58.34M$60.08M$41.81M
Surprise %-----------------1.08%1.30%1.44%1.10%1.00%1.04%1.19%1.02%1.17%1.28%0.71%1.19%2.87%

Aurora Cannabis's average Quarter SG&A projection for Mar 23 is $43.13M, based on 1 Wall Street analysts, with a range of $43.13M to $43.13M. The forecast indicates a -3.22% fall compared to ACB last annual SG&A of $44.57M (Dec 22).

Aurora Cannabis EPS Forecast

Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19
# Analysts1111111111211311111111177111010116
EPS-----------------$-0.21$-0.17$-2.88$-4.72$-0.38$-0.06$-0.65$-0.85$-1.74$-0.92$-15.94$-1.37$-14.16
Avg Forecast$0.12$0.12$0.11$0.05$0.04$0.04$0.03$-0.04$-0.04$-0.08$-0.11$-0.17$-0.18$-0.13$-0.65$-0.52$-0.40$-2.58$-0.85$-1.27$-2.72$-2.49$-3.08$-3.87$-6.06$-7.43$-10.12$-6.51$-7.23$-5.82
High Forecast$0.12$0.12$0.11$0.05$0.04$0.04$0.03$-0.04$-0.04$-0.08$0.02$-0.17$-0.18$-0.13$-0.22$-0.52$-0.40$-2.58$-0.85$-1.27$-2.72$-2.49$-3.08$-3.87$-6.06$-7.43$-10.12$-6.51$-7.23$-5.82
Low Forecast$0.12$0.12$0.11$0.05$0.04$0.04$0.03$-0.04$-0.04$-0.08$-0.24$-0.17$-0.18$-0.13$-0.86$-0.52$-0.40$-2.58$-0.85$-1.27$-2.72$-2.49$-3.08$-3.87$-6.06$-7.43$-10.12$-6.51$-7.23$-5.82
Surprise %-----------------0.08%0.20%2.26%1.73%0.15%0.02%0.17%0.14%0.23%0.09%2.45%0.19%2.43%

According to undefined Wall Street analysts, Aurora Cannabis's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to ACB previous annual EPS of $NaN (undefined).

Aurora Cannabis Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
TLRYTilray Brands$1.73$7.42328.90%Hold
CGCCanopy Growth$5.49$14.47163.57%Hold
SNDLSNDL$2.16$3.9582.87%Hold
CRONCronos Group$2.20$3.4355.91%Hold
ACBAurora Cannabis$5.98$5.92-1.00%Hold

ACB Forecast FAQ


No, according to 7 Wall Street analysts, Aurora Cannabis (ACB) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 28.57% of ACB's total ratings.

Aurora Cannabis (ACB) average price target is $5.92 with a range of $1 to $8.75, implying a -1.00% from its last price of $5.98. The data is based on 7 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

According to Wall Street analysts' prediction for ACB stock, the company can go down by -1.00% (from the last price of $5.98 to the average price target of $5.92), up by 46.37% based on the highest stock price target, and down by -83.28% based on the lowest stock price target.

ACB's average twelve months analyst stock price target of $5.92 does not support the claim that Aurora Cannabis can reach $9 in the near future.

Aurora Cannabis's analysts financial forecasts for the fiscal year (Jun 2025) are as follows: average revenue is $221.53M (high $222.35M, low $220.72M), average EBITDA is $-134M (high $-134M, low $-135M), average net income is $-12.638M (high $-6.513M, low $-18.764M), average SG&A $190.21M (high $190.91M, low $189.51M), and average EPS is $-0.267 (high $-0.137, low $-0.396). ACB's analysts financial forecasts for the fiscal year (Jun 2026) are as follows: average revenue is $220.91M (high $220.91M, low $220.91M), average EBITDA is $-134M (high $-134M, low $-134M), average net income is $7.34M (high $7.34M, low $7.34M), average SG&A $189.67M (high $189.67M, low $189.67M), and average EPS is $0.155 (high $0.155, low $0.155).

Based on Aurora Cannabis's last annual report (Jun 2022), the company's revenue was $221.34M, beating the average analysts forecast of $195.52M by 13.20%. Apple's EBITDA was $-143M, missing the average prediction of $-19.254B by -99.26%. The company's net income was $-1.718B, missing the average estimation of $-20.433B by -91.59%. Apple's SG&A was $188.99M, beating the average forecast of $167.88M by 12.58%. Lastly, the company's EPS was $-7.99, missing the average prediction of $-9.561 by -16.44%. In terms of the last quarterly report (Dec 2022), Aurora Cannabis's revenue was $61.68M, beating the average analysts' forecast of $47.95M by 28.63%. The company's EBITDA was $-53.868M, beating the average prediction of $-29.092M by 85.17%. Aurora Cannabis's net income was $-67.183M, missing the average estimation of $-122M by -45.03%. The company's SG&A was $44.57M, beating the average forecast of $41.17M by 8.25%. Lastly, the company's EPS was $-0.21, missing the average prediction of $-2.577 by -91.85%